everettAbbott (@eAbizdev) profile picture

everettAbbott

@eAbizdev
 Boulder, CO
everettAbbott.com
Joined April 2016
  • Tweets10
  • Following7
  • Followers7
Catalyzing small molecule collaboration: opnme.com @Boehringer @boehringerus @WellspringWW
1
1
everettAbbott retweeted
AngelMD (@angelMD_Inc) profile picture
AngelMD@angelMD_Inc24 Oct 2017
.@articulusbio takes a unique approach in solving the problems behind total joint replacement failures. Learn more: angl.md/2zBqI8b
3
2
3
Today is #WorldArthritisDay. Learn more about this condition and how it can affect the foot/ankle. @AAOS1 orthoinfo.aaos.org/topic.cfm…
3
“The only thing worse than training your EEs and having them leave is not training them and having them stay.” —HF hbr.org/2017/10/what-science…
1
#Amen xitter.cf/mountsinainyc/status/9…
Mount Sinai Health System (@MountSinaiNYC) profile pictureMount Sinai Health System
@MountSinaiNYC11 Sep 2017
On the anniversary of 9/11, let us remember all that was lost, honor those that died while serving us, & fight for a better, healthier world
Image from Mount Sinai Health System (@MountSinaiNYC)
1
Breaking News: @WellspringWW acquires @CovalentData prnewswire.com/news-releases…
Where will innovations of tomorrow emerge from? Pay careful attention to 🇨🇳 and 🇮🇳 xitter.cf/wef/status/75966041103…
World Economic Forum (@wef) profile pictureWorld Economic Forum
@wef31 Jul 2016
There's a research revolution going on in #China – and one day it could save your life wef.ch/2a5jCBM
Image from World Economic Forum (@wef)
1
How @JNJCares $JNJ is recalibrating Open Innovation to benefit all players @JNJInnovation #JLabs fortune.com/2016/07/22/the-r…
The Radical Experiment That’s Changing the Way Big Pharma Innovates | Fortune

The Radical Experiment That’s Changing the Way Big Pharma Innovates | Fortune

J&J throws open its R&D doors to build relationships with startups

fortune.com
1
1
Must Read: PDUFA Reauthorization Performance Goals & Procedures Fiscal Yrs 2018-2022 fda.gov/downloads/ForIndustr…
2
Evaluation of #Aramchol + VitD 4 Treatment of Fibrotic Nonalcoholic Fatty Liver Disease @GalmedPharma @MountSinai_IP xitter.cf/arubenstein/status/732…
Adam Rubenstein (@arubenstein) profile pictureAdam Rubenstein@arubenstein17 May 2016
buff.ly/1rhNhug @MountSinaiNYC and @GalmedPharma to Collaborate in a Phase IIa Trial $GLMD @MountSinai_IP #LiverDisease
Load more